AT
Andrea Tan Goldman Sachs Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
13
Avg Return
Past Year
Past Year
36%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
76.9%
Neutral
23.1%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $327 |
25%
upside
| 1 | -6.4% |
0
%
| 2 Feb ‘26 1 month ago |
|
|
|
Neutral
Maintained
| $85 |
43%
upside
| 2 | – |
–
| 7 Jan ‘26 2 months ago |
|
|
|
Buy
Maintained
| $225 |
56%
upside
| 6 | +10% |
0
%
| 18 Dec ‘25 2 months ago |
|
|
|
Buy
Maintained
| $8 |
54%
upside
| 2 | +76% |
0
%
| 12 May ‘25 10 months ago |
|
|
|
Neutral
Maintained
| $51 |
29%
downside
| 1 | – |
–
| 5 May ‘25 10 months ago |
|
|
|
Buy
Maintained
| $27 |
27%
upside
| 1 | +157% |
0
%
| 25 Mar ‘25 11 months ago |
|